Cite

HARVARD Citation

    Baldo, A. et al. (2016). Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination. Human vaccines & immunotherapeutics. 12 (5), pp. 1102-1116. [Online]. 
  
Back to record